Why Does Diversity In Clinical Trials Continue To Be A Challenge For Biopharma Companies And What ThoughtsIdeas Do You Have On How To Overcome

See the answer from Mitchell Katz, Ph.D., VP, development operations at Ferring Pharmaceuticals.

Related Keywords

Mitch Katz , ,